Ring Therapeutics IPO

ringtx.com

Ring Therapeutics is a biotech company focused on developing Gene Therapy and Nucleic Acid Medicines by harnessing the human commensal virome.

Founded2017
Total Funding to Date$142.14MM
Register for Details

For more details on financing and valuation for Ring Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Ring Therapeutics Ticker Symbol

Ring Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Ring Therapeutics Stock Price

The stock price for Ring Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Ring Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
7/28/2021 Series B $483.73MM $XXX.XX $XXX.XX
1/3/2020 Series A and A-1 $80.36MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Ring Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM